OAB-021: BCMA-specific ADC MEDI2228 and Daratumumab induce synergistic myeloma cytotoxicity via enhanced IFN-driven innate immune responses and expression of CD38 and NKG2D ligands
Titel:
OAB-021: BCMA-specific ADC MEDI2228 and Daratumumab induce synergistic myeloma cytotoxicity via enhanced IFN-driven innate immune responses and expression of CD38 and NKG2D ligands
Auteur:
Xing, Lijie Wang, Su Liu, Jiye Yu, Tengteng Chen, Hailin Wen, Kenneth Hsieh, Phillip Cho, Shih-Feng An, Gang Qiu, Lugui Munshi, Nikhil C. Anderson, Kenneth Tai, Yu-Tzu